WPI 2775
Pill imprint WPI 2775 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; insulin resistance syndrome; female infertility; polycystic ovary syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Metformin hydrochloride Images
- Imprint:
-
WPI
2775 - Strength:
- 850 mg
- Color:
- Orange
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
hypromellose
lactose monohydrate
ferric oxide red
titanium dioxide
triacetin
vanillin
ferric oxide yellow
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-2775
Advertisement
More Metformin Hydrochloride resources
- Metformin
- Metformin (Wolters Kluwer)
- Metformin Extended-Release Tablets (Wolters Kluwer)
- Metformin Solution (Wolters Kluwer)
- metformin (Cerner Multum)
- metformin (Micromedex) - Includes Dosage Information
- Metformin Hydrochloride (AHFS DI)
- Metformin (FDA)
- Metformin Extended Release (FDA)
- Metformin Hydrochloride (Wolters Kluwer)
Search Again
